Home Clairity

Clairity

In operation
Series B
Breast Cancer Prediction AI Platform
Basic
Enterprise Profile

Basic Information

Clairity is an AI-driven precision health company dedicated to transforming medical imaging into a predictive tool for early risk assessment. Its flagship product, Clairity Breast, is the first FDA-approved platform that estimates a woman’s five-year breast cancer risk directly from routine mammograms. By shifting care from detection to prevention, Clairity enables health systems, radiologists, and women to take earlier action, save lives, and reduce the overall cost of cancer care.
Clairity, Inc.
Boston,Massachusetts,United States of America
15~50 people
January 01, 2021
ngill@lavoiehealthscience.com

Enterprise Profile

Industrial Sector
Medical Device R&D and Design # Diagnostic Manufacturing
Technology
Medical Imaging Technology Deep Learning
Concept
Imaging Diagnosis Breast Cancer
Application Scenarios
Medical Devices AI + Medical Devices Early Disease Screening